Dr. Tomas Mustelin, MD, D. Med. Sci. will be appointed as a Professor of Medicine with the Division in on July 2018.
Dr. Mustelin will be based at our South Lake Union campus. He received his MD and D. Med. Sci. (PhD equivalent) from the University of Helsinki , Finland. Dr. Mustelin completed his postdoctoral training at the Research Institute of Scripps Clinic, La Jolla, California. Between 1991 and 2007, Dr. Mustelin had a very successful academic career, achieving the rank of full professor in just seven years before moving to an industry position.
In 2007, he moved to Seattle as the Amgen site scientific director. In 2011, he accepted the position of Vice President of Research at MedImmune based out of Gaithersburg, Maryland. Dr. Mustelin returned to Seattle where he worked as the Vice President of Immunology and Inflammation at Gilead Sciences and led the preclinical Immuno-oncology, Viral Immunology, and Inflammation. He is currently also an Adjunct Professor at Sanford Burnham Institute for Medical Research, La Jolla, CA and a Member of the UCSD Clinical and Translational Research Institute (CTRI). Dr. Mustelin is committed to working on translational projects relevant to rheumatology and has served as a mentor for over 37 postdoctoral trainees and has over 230 original articles and reviews. His major contributions have been in discovery of kinases and phosphatases that regulate immune cell signal transduction (published in Cell and the Nature group of journals). These discoveries (especially PTPN22) have particular relevance to rheumatology as variants in the gene encoding this protein are increased in rheumatoid arthritis and other autoimmune diseases.